Protective efficacy of pneumococcal polysaccharide vaccines

P. Smit, D. Oberholzer, S. Hayden-Smith, H. J. Koornhof and M. R. Hilleman

Clinical studies of 6- and 12-valent pneumococcal capsular polysaccharide vaccines were carried out in controlled studies among novice gold miners in South Africa. In the studies 1,523 persons received pneumococcal vaccine, and 3,171 were included as controls. In the great majority of subjects given pneumococcal vaccine, antibodies developed against the capsular types included in the vaccine. The 6-valent vaccine afforded 76% reduction in cases of laboratory-verified pneumococcal pneumonia caused by the homologous types, and there was 92% reduction in the cases afforded by the 12-valent vaccine. The vaccines were well tolerated and offer great promise for effective control of illnesses caused by pneumococci.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emergence of Novel Streptococcus iniae Exopolysaccharide-Producing Strains following Vaccination with Nonproducing Strains
Eyngor et al.
Appl. Environ. Microbiol. 2008;74:6892-6897.
ABSTRACT | FULL TEXT  

Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine following Invasive Pneumococcal Disease
Borrow et al.
Infect. Immun. 2008;76:5305-5309.
ABSTRACT | FULL TEXT  

Pneumococcal Vaccination for Patients With COPD: Current Practice and Future Directions
Schenkein et al.
Chest 2008;133:767-774.
ABSTRACT | FULL TEXT  

Assessment of the Protective Effect of Pneumococcal Vaccination in Preventing Meningitis After Cochlear Implantation
Wei et al.
Arch Otolaryngol Head Neck Surg 2007;133:987-994.
ABSTRACT | FULL TEXT  

Pneumococcal Capsular Polysaccharide Vaccine-Mediated Protection against Serotype 3 Streptococcus pneumoniae in Immunodeficient Mice
Tian et al.
Infect. Immun. 2007;75:1643-1650.
ABSTRACT | FULL TEXT  

Guidelines for the management of adult lower respiratory tract infections
Woodhead et al.
Eur Respir J 2005;26:1138-1180.
ABSTRACT | FULL TEXT  

In Vivo Humoral Immune Responses to Isolated Pneumococcal Polysaccharides Are Dependent on the Presence of Associated TLR Ligands
Sen et al.
J. Immunol. 2005;175:3084-3091.
ABSTRACT | FULL TEXT  

Endpoints in vaccine trials
Hudgens et al.
Stat Methods Med Res 2004;13:89-114.
ABSTRACT  

Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases
O'Brien and Santosham
Am J Epidemiol 2004;159:634-644.
ABSTRACT | FULL TEXT  

Bull's Eye: Unraveling the Medical Mystery of Lyme Disease
Dardick
JAMA 2003;290:3005-3006.
FULL TEXT  

Cost-Effectiveness of the Pneumococcal Vaccine in Healthy Younger Adults
Pepper and Owens
Med Decis Making 2002;22:S45-S57.
ABSTRACT  

Recovery of Streptococcus iniae from Diseased Fish Previously Vaccinated with a Streptococcus Vaccine
Bachrach et al.
Appl. Environ. Microbiol. 2001;67:3756-3758.
ABSTRACT | FULL TEXT  

Pneumococcal vaccination: current and future issues
Ortqvist
Eur Respir J 2001;18:184-195.
ABSTRACT | FULL TEXT  

The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease
Nichol et al.
Arch Intern Med 1999;159:2437-2442.
ABSTRACT | FULL TEXT  

Serotyping of Streptococcus pneumoniae by Coagglutination with 12 Pooled Antisera
Lalitha et al.
J. Clin. Microbiol. 1999;37:263-265.
ABSTRACT | FULL TEXT  

Antibody Responses to Capsular Polysaccharide Backbone and O-Acetate Side Groups of Streptococcus pneumoniae Type 9V in Humans and Rhesus Macaques
McNeely et al.
Infect. Immun. 1998;66:3705-3710.
ABSTRACT | FULL TEXT  

Pneumococcal Vaccine in Children
Granoff
CLIN PEDIATR 1980;19:96-98.